Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Abstract Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination therapies. This study aimed to evalu...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2025-04-01
Serija:	Cardiology and Therapy
Teme:	Hypertension Cardiovascular disease Losartan Chlorthalidone Hydrochlorothiazide
Online dostop:	https://doi.org/10.1007/s40119-025-00407-7
Oznake:	Označite Brez oznak, prvi označite!